Detection and viability of waterborne pathogens using a gut-on-chip. This project aims to resolve a significant problem for water utilities. Microbial pathogens Cryptosporidium, norovirus and adenovirus are the main public health concern for drinking water in developed nations. Water monitoring is limited by the lack of fast, reliable detection methods and viability assays for these pathogens. This project will use a novel gut-on-a-chip to develop for the first time rapid infectivity assays for ....Detection and viability of waterborne pathogens using a gut-on-chip. This project aims to resolve a significant problem for water utilities. Microbial pathogens Cryptosporidium, norovirus and adenovirus are the main public health concern for drinking water in developed nations. Water monitoring is limited by the lack of fast, reliable detection methods and viability assays for these pathogens. This project will use a novel gut-on-a-chip to develop for the first time rapid infectivity assays for Cryptosporidium, norovirus and adenovirus. Significant benefits include improved diagnostics and water disinfection assays, improved water treatment and reduced costs with global impact.Read moreRead less
The molecular basis of zinc toxicity to Gram-positive bacteria. Gram-positive bacteria are a major cause of infectious diseases in both developed and developing countries. This project will contribute to our understanding of how zinc causes toxicity to these bacteria and facilitate our exploitation of this Achilles heel, by providing new insights into fundamental aspects of microbial physiology.
A comparative study of the distribution and spread of potential molecular markers for Mundulla Yellows disease. Mundulla Yellows (MY), a newly recognised widespread lethal disease of Eucalyptus spp.in Australia, is a serious threat to national biodiversity and conservation. It is contagious, apparently biotic, but the causal agent is unknown. Identification of the cause is essential to establish sustainable control measures. We have detected a range of MY-associated RNAs constituting a disease ' ....A comparative study of the distribution and spread of potential molecular markers for Mundulla Yellows disease. Mundulla Yellows (MY), a newly recognised widespread lethal disease of Eucalyptus spp.in Australia, is a serious threat to national biodiversity and conservation. It is contagious, apparently biotic, but the causal agent is unknown. Identification of the cause is essential to establish sustainable control measures. We have detected a range of MY-associated RNAs constituting a disease 'fingerprint'. To identify individual RNAs uniquely associated with MY we aim to compare MY-RNA fingerprints from a range of affected species from different sites and with varying symptoms. Candidate RNAs will be cloned both for establishing molecular diagnostics for MY and identifying the cause.Read moreRead less
Development of a vaccine to protect koalas against koala retrovirus (KoRV). This project aims to develop a vaccine against koala retrovirus (KoRV) to arrest the increasing loss of animals due to this infection. Along with Chlamydia, KoRV threatens the long-term survival of the koala. KoRV infects over 95 per cent of Australia’s koalas and has been strongly linked to lymphoma and leukemia. Although quarantine and antiretroviral drug treatment are possible control measures, they are impractical in ....Development of a vaccine to protect koalas against koala retrovirus (KoRV). This project aims to develop a vaccine against koala retrovirus (KoRV) to arrest the increasing loss of animals due to this infection. Along with Chlamydia, KoRV threatens the long-term survival of the koala. KoRV infects over 95 per cent of Australia’s koalas and has been strongly linked to lymphoma and leukemia. Although quarantine and antiretroviral drug treatment are possible control measures, they are impractical in the wild, leaving vaccination as the only realistic option. This is valuable for both wild and captive koalas; zoos report high animal losses due to KoRV-associated lymphoma. The main outcome will be a KoRV vaccine which can be combined with a Chlamydia vaccine which is being developed in parallel.Read moreRead less